Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

nauchnyy_seminar

Pharmasyntez asks Russian Government for permission to produce generic version of remdesivir for COVID-19

November 2, 2020 Sales and Marketing

Russian drug firm Pharmasyntez has asked the government for permission to produce a generic version of Gilead’s remdesivir without a …
News
shutterstock_273326141

Sanofi angles to buy Kiadis for €308 million

November 2, 2020 Sales and Marketing Sanofi, kiadis, pharma

Sanofi has announced it is poised to buy out Amsterdam-based biopharma firm Kiadis in an all-cash public offer of €308 …
News
dermatitis2015_-_copy

LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema

November 2, 2020 Research and Development, Sales and Marketing LEO Pharma, eczema, pharma

LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …
News
parag_agarwal_-17485

Parag Agarwal appointed as Dr Reddy’s Laboratories Chief Financial Officer

October 30, 2020 Sales and Marketing

Dr Reddy’s Laboratories has appointed Parag Agarwal has the company’s new Chief Financial Officer. Parag has a career that spans …
Appointment
nice_new_london_office_internal_3_web

NICE recommends Novo’s liraglutide for management of obesity and non-diabetic hyperglycaemia

October 30, 2020 Medical Communications, Sales and Marketing NICE, Novo Nordisk, liraglutide

Novo Nordisk’s pre-filled injection Saxenda (liraglutide) has received the backing of drug watchdog NICE, meaning it will now be made …
News
shutterstock_87495637

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …
News
europe-1395916_640

European Commission greenlights Insmed’s Arikayce for nontuberculous mycobacterial lung infections

October 29, 2020 Sales and Marketing Arikayce, EU, lungs, pharma

The European Commission (EC) has given approval to Insmed Incorporated’s Arikayce (liposomal 590mg nebuliser dispersion) for the treatment of nontuberculous …
News
bugbuster

FDA approves Sanofi’s ivermectin head lice treatment for over-the-counter use

October 29, 2020 Sales and Marketing

The FDA has approved Sanofi’s Sklice (ivermectin) for over-the-counter use.  Sklice is a single-use lotion that includes ivermectin 0.5% as …
News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …
News
lilly_building_with_american_flag_web

US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal

October 28, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma

The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …
News
pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!
News

Bayer buys out US-based Asklepios BioPharmaceutical in potential $4bn deal

October 26, 2020 Sales and Marketing Asklepios, Bayer, acquisition, pharma

Bayer has moved to bolster its cell and gene therapy (CGT) business through the acquisition of US biotech Asklepios BioPharmaceutical …
News
astrazeneca-sign

AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants

October 26, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine

AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …
News
800px-industria_novartis_1

Novartis announces positive Phase 2 data of rare renal disease therapy iptacopan

October 26, 2020 Sales and Marketing

Novartis has announced positive Phase 2 interim analysis results for iptacopan, which is an investigational oral treatment for rare renal …
News
706px-fentanyl_lollipops_actiq_400_mcg

UK Government outlines steps to tackle growing misuse of fentanyl

October 26, 2020 Sales and Marketing

The British Government has responded to a report investigating the misuse of fentanyl and painkillers in the UK. In January …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026